Vol 55, No 3 (2024)
Clinical vignette
Published online: 2024-06-24

open access

Page views 108
Article views/downloads 50
Get Citation

Connect on Social Media

Connect on Social Media

Hyperleukocytosis and leukostasis as fatal consequences of childhood acute myeloid leukemia

Ewelina Truszkowska1, Jakub Czarny2, Dominika Galli2, Katarzyna Adamczewska-Wawrzynowicz3, Magdalena Samborska3, Maksymilian Deręgowski3, Katarzyna Jończyk-Potoczna4, Katarzyna Derwich3
DOI: 10.5603/ahp.99242
Acta Haematol Pol 2024;55(3):174-176.

Abstract

< p > < /p >

Article available in PDF format

View PDF Download PDF file

References

  1. Morais RV, Souza MV, Silva KA, et al. Epidemiological evaluation and survival of children with acute myeloid leukemia. J Pediatr (Rio J). 2021; 97(2): 204–210.
  2. Macaron W, Sargsyan Z, Short NJ. Hyperleukocytosis and leukostasis in acute and chronic leukemias. Leuk Lymphoma. 2022; 63(8): 1780–1791.
  3. Kittivisuit S, Jongthitinon N, Sripornsawan P, et al. Hyperleukocytosis in childhood acute leukemia: early complications and survival outcomes. Cancers (Basel). 2023; 15(12): 3072.
  4. Bewersdorf JP, Zeidan AM. Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better understanding of the underlying molecular pathophysiology lead to novel treatments? Cells. 2020; 9(10): 2310.
  5. Spring J, Munshi L. Oncologic emergencies: traditional and contemporary. Crit Care Clin. 2021; 37(1): 85–103.
  6. Christakopoulos G, Walker K, Wang L, et al. Clinical features and cytoreduction therapy in children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Blood. 2021; 138(Supplement 1): 2295–2295.